3 completed, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Aradigm Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) Ciprofloxacin dispersion for inhalation, Placebo - Non Cystic Fibrosis Bronchiectasis | Phase 3 | Completed | Aradigm Corporation | 304 | 2014-05-28 | 2021-03-26 |
| Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) Ciprofloxacin dispersion for inhalation, Placebo - Non Cystic Fibrosis Bronchiectasis | Phase 3 | Completed | Aradigm Corporation | 278 | 2014-03-31 | 2021-03-26 |
| Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa Antibiotic - Cystic Fibrosis | Withdrawn | Aradigm Corporation | 2010-09-01 | 2023-11-22 | ||
| Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1" Ciprofloxacin for Inhalation, Placebo - Non-Cystic Fibrosis Bronchiectasis | Phase 2 | Completed | Aradigm Corporation | 95 | 2010-02-01 | 2017-01-25 |
Pseudomonas Infections (2) · Bronchiectasis (1) · Cystic Fibrosis (1) · Respiratory Aspiration (1)
Inhalation (3) · Anti-Bacterial Agents (1) · Ciprofloxacin (1)
Canada (3) · United Kingdom (3) · United States (3) · Australia (2) · Germany (2) · Hungary (2) · Israel (2) · Italy (2) · Poland (2) · Romania (2) · South Korea (2) · Spain (2) · France (1) · Georgia (1) · Ireland (1)
P Bruinenber, MD (1) · Paul Bruinenberg, MBChB, MBA (1)